Company Search:
Advanced Search
Sponsored Links
Vivus, Inc. Company Snapshot
Vivus, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vivus with three other companies in this sector in the United States: Spring Pharmaceutical Group Inc (2018 sales of $64.94 million ), Akcea Therapeutics Inc ($64.87 million ), and Lexicon Pharmaceuticals Incorporated ($63.21 million of which 100% was Pharmaceutical R&D).

Sales Analysis. During the year ended December of 2018, sales at Vivus were $65.06 million. This is a decrease of 0.5% versus 2017, when the company's sales were $65.37 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vivus, Inc.
  Stock Performance Chart for Vivus, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 2.72
(Figures in U.S. Dollars)
1 Week -2.2%   13 Weeks 4.2%  
4 Weeks -36.5%   52 Weeks -35.2%  
Vivus, Inc. Key Data:
  Ticker: VVUS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 65,062,000
(Year Ending Jan 2019).
Employees: 57
  Currency: U.S. Dollars Market Cap: 28,948,179
  Fiscal Yr Ends: December Shares Outstanding: 10,642,713
  Share Type: Common Closely Held Shares: 851,572
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.